The efficacy of brimonidine in preventing intraocular pressure elevation in the provocative test for primary angle-closure glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 2, 2002, Pages 99-103

  Chen, Yuh Fang ^a   Hung, Por T ^a   Hsieh, Jui Wei ^a   Shein, Jean ^a   Hsiao, Chuhsing K ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLOSED ANGLE GLAUCOMA; CONTROLLED STUDY; DARKNESS; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; PROVOCATION TEST; TREATMENT OUTCOME;

EID: 0036217048     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076802317373851     Document Type: Article

References (11)

1. Angle-closure glaucoma
2. Medical therapy in primary angle-closure glaucoma: A model for evaluation of its efficacy
3. Provocation and medical treatment in post-iridectomy glaucoma
4. Primary angle closure glaucoma without pupillary block (plateau iris)
5. Effects of brimonidine on aqueous humor dynamics in human eyes
6. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure
7. Effect of brimonidine 0.5% on intraocular pressure spikes following 360° argon laser trabeculoplasty
8. Provocation and mechanism of angle-closure glaucoma after iridectomy
9. Introduction and classification of the glaucoma
10. Iridectomy in advanced angle closure glaucoma
11. Elevated pressure in the prone position. A new provocative test for angle-closure glaucoma